Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:24 PM ET 10-Q
Financial Results Lightpath Technologies Inc LPTH

Lightpath Technologies Q1 2026 Results: Net Loss of $1.7M, Loss Narrows

LightPath Technologies reported revenue of $20.8 million for the quarter ended September 30, 2026, a 38% increase compared to the prior year. Despite the revenue growth, the company recorded a net loss of $1.7 million, driven by significantly higher operating expenses in selling, general, and administrative costs and new product development.

Key figure
Net loss $1.7M
4:24 PM ET 8-K
Loan & Debt Akamai Technologies Inc AKAM

Akamai Technologies $2.2B Debt Financing

Akamai Technologies priced a private offering of $2.2 billion in aggregate principal amount of 1.00% convertible senior notes, split equally between tranches due in 2028 and 2031. The company also granted initial purchasers an option to buy up to an additional $300 million in notes. The proceeds are intended for general corporate purposes, including potential debt refinancing or share repurchases.

Value
$2.2B
Term
through Nov 2031
4:24 PM ET 8-K
Financial Results Sonos Inc SONO

Sonos Financial Results

Sonos reported fiscal year 2026 revenue growth of 7% to $1.55 billion and a 39% increase in Adjusted EBITDA to $184 million. Alongside the results, the company announced that its Board of Directors authorized a new $150 million common stock repurchase program following the completion of its previous buyback program.

“We said Fiscal 2026 would be the year Sonos returned to growth, and we delivered. We grew in every region, delivered meaningfully higher profitability, and brought five new products to market. Underneath it all, the system strategy is working - every product improves those our customers already own, and with Sonos 27, that will keep getting stronger every year.”

Tom Conrad, Chief Executive Officer of Sonos

“Fiscal 2026 demonstrated how much the earning power of Sonos has structurally improved. We grew revenue 7%, reduced Non-GAAP operating expenses 3% and grew Adjusted EBITDA 39% to $184 million, all while absorbing $56 million of higher memory costs. That’s the foundation we’re building on, and we’re actively managing the levers available to us to optimize our financial performance.”

Saori Casey, Chief Financial Officer of Sonos
4:24 PM ET 8-K
Financial Results Context Therapeutics Inc. CNTX

Context Therapeutics Financial Results

Context Therapeutics reported Q3 2026 financial results and provided a clinical update on its CTIM-76 program, which showed a 22% confirmed ORR and 5.6 months median PFS in platinum-resistant ovarian cancer. The company ended the quarter with $34.4 million in cash, providing a runway into Q4 2027.

Term
Q3 2026

“CTIM-76 continues to show promising activity in patients with PROC who had received a median of six prior lines of therapy. Our Phase 1b strategy is to evaluate CTIM-76 in patients with no more than five prior lines of therapy. These less heavily pretreated patients generally have lower tumor burden and better T cell fitness, providing a rationale to evaluate whether treatment in this population, together with Q3W dosing, can deliver greater clinical benefit and improved tolerability.”

Martin Lehr, Chief Executive Officer
4:23 PM ET 8-K
M&A Deal Centerspace CSR

Centerspace M&A Deal with Independence Realty Trust, Inc.

Centerspace shareholders and Independence Realty Trust (IRT) stockholders approved the previously announced merger between the two multifamily REITs. Upon closing, Centerspace shareholders will receive 3.800 shares of IRT common stock for each share owned. The deal remains subject to remaining closing conditions, including lender consents for certain mortgage loans.

Counterparty
Independence Realty Trust, Inc.
4:23 PM ET 8-K
Financial Results Palisade Bio, Inc. PALI

Palisade Bio Financial Results

Palisade Bio reported third quarter 2026 financial results and provided a clinical update on its PALI-2108 programs, including the initiation of the Phase 2b ASCENTRA-UC trial. The company ended the quarter with $113.6 million in cash and expects topline results from the UC trial in Q4 2027.

“ASCENTRA-UC is now underway, and our focus is on driving enrollment and executing the study to deliver topline results in the fourth quarter of 2027. With nearly all planned U.S. sites activated, we are expanding our global clinical footprint to build on that progress.”

JD Finley, Chief Executive Officer of Palisade Bio

“In parallel, we are preparing to initiate ASCENTRA-CD, with initiation of enrollment targeted for the first quarter of 2027. Our strong financial position supports execution across both programs as we work to establish PALI-2108’s potential as a differentiated, once-daily oral treatment for patients living with IBD.”

JD Finley, Chief Executive Officer of Palisade Bio
4:23 PM ET 8-K
Capital Raise Hyundai Auto Receivables Trust 2026-D

Hyundai Auto Receivables Trust 2026-D Capital Raise

Hyundai Auto Receivables Trust 2026-D completed the issuance and sale of several classes of asset-backed notes on November 10, 2026. The transaction involved the transfer of retail installment sale contracts for automobiles from Hyundai Capital America to the trust vehicle. This filing formalizes the definitive agreements, including the Indenture and Sale and Servicing Agreement, related to the securitization.

4:22 PM ET 8-K
Capital Raise Hagerty, Inc. HGTY

Hagerty Capital Raise

Hagerty announced the commencement of an underwritten secondary public offering of 9,000,000 shares of its Class A common stock by Hagerty Holding Corp. The selling stockholder also intends to grant underwriters a 30-day option to purchase up to an additional 1,350,000 shares. Hagerty will not receive any proceeds from the sale, as the net proceeds will be used by the selling stockholder to redeem shares for the benefit of the Kim Hagerty Revocable Trust.

Counterparty
Hagerty Holding Corp.
4:22 PM ET 8-K
Financial Results Seer, Inc. SEER

Seer Financial Results

Seer, Inc. reported third quarter 2026 revenue of $4.0 million, a sequential increase from $3.1 million in Q2 2026, driven by consumable purchases from established customers and new pharmaceutical platform adoptions. The company ended the quarter with $198.1 million in cash and updated its full-year 2026 revenue guidance to a range of $13.5 million to $14.5 million.

Term
Q3 2026

“This quarter, our customers continued to demonstrate what Proteograph makes possible, from new discoveries in population-scale research to emerging applications in AI, while established customers returned to purchase consumables and new pharmaceutical customers adopted the platform.”

Omid Farokhzad, Chair and Chief Executive Officer

“Proteograph fundamentally expands the biology researchers can see with mass spectrometry. Our focus is to translate that differentiated value into sustained revenue growth by expanding sample volume within customer accounts and building relationships that support repeat use. With a strong balance sheet and growing evidence of the platform’s value, I remain confident in Seer’s opportunity and committed to building long-term value for our shareholders.”

Omid Farokhzad, Chair and Chief Executive Officer
4:22 PM ET 8-K
Financial Results Swarmer, Inc SWMR

Swarmer Financial Results

Swarmer, Inc. reported Q3 2026 financial results, highlighting its transition from a software provider to an integrated defense solutions supplier. The company is nearing the close of its acquisition of Ratel Robotics and announced a pending IP acquisition from Vataga Drone to bolster its hardware capabilities. Reported revenue for the quarter was $25,554, primarily from support services, as the pending Ratel acquisition's performance is not yet consolidated.

Term
Q3 2026

“The third quarter marked a pivotal period for Swarmer as we made meaningful progress toward our vision of bringing combat-tested technologies from Ukraine to allied nations.”

Alex Fink, Swarmer’s President and U.S. CEO

“Ground vehicles, air defense and integrated autonomous drone kits represent the three pillars of our expanding market position.”

Alex Fink, Swarmer’s President and U.S. CEO
4:22 PM ET 8-K
Stock Plan Amendment Price T Rowe Group Inc TROW

Price T Rowe Group Stock Plan Amendment

T. Rowe Price Group amended its 2020 Long-Term Incentive Plan and related grant notices to modify vesting provisions. The changes allow for the continued vesting of equity awards for employees following certain involuntary terminations and introduce new vesting terms for future grants.

4:21 PM ET 8-K
Loan & Debt Air Industries Group AIRI

Air Industries Group Debt Financing Update with Michael Taglich and Robert Taglich

Air Industries Group entered into a Thirteenth Amendment to its Loan and Security Agreement, extending the maturity date of its revolving credit and term loans to April 30, 2027. Concurrently, the company extended the maturity of its related party subordinated notes held by Michael and Robert Taglich to May 1, 2027. The extensions include fee payments and potential interest rate increases if a contemplated merger with Tenax Aerospace Acquisition does not occur by November 30, 2026.

Counterparty
Michael Taglich and Robert Taglich
Term
through May 2027
4:21 PM ET Form 4
Insider Buying Fidelity National Information Services, Inc. FIS

Fidelity National Information Services Insider Kourtney Gibson Buys $52.2K of Stock

Kourtney Gibson bought 1,800 shares of Fidelity National Information Services, Inc. at $29.00 a share, worth $52.2K in total on Nov 6, 2026. Shares held after the trade: 5,903 (+43.9%).

Value
$52.2K
Shares
1,800
Price
$29.00
Holding change
+43.9%
Trade date
Nov 6, 2026
4:21 PM ET 10-Q
Financial Results BridgeBio Oncology Therapeutics, Inc. BBOT

BridgeBio Oncology Therapeutics Q3 2026 Results: Net Loss of $34.2M, Loss Narrows

BridgeBio Oncology Therapeutics reported a net loss of $34.2 million for the third quarter of 2026, an improvement from the $44.8 million loss in the prior year period. Total assets decreased to $346.2 million from $448.4 million at year-end 2025, primarily driven by a significant reduction in cash and cash equivalents as the company continues to fund its research and development operations.

Key figure
Net loss $34.2M
4:21 PM ET 10-Q
Financial Results Airgain Inc AIRG ▶ Call

Airgain Q3 2026 Results: Net Loss of $583K, Loss Narrows

Airgain, Inc. reported sales of $15.3 million for the third quarter of 2026, a 9.3% increase compared to the same period in 2025. The company narrowed its net loss to $0.6 million for the quarter, down from a $1.0 million loss in the prior year, driven by higher gross profit and reduced operating expenses.

Key figure
Net loss $583K
4:21 PM ET Form 4
Insider Selling Sportradar Group AG SRAD

Sportradar Group CAO James Scott Ritter Sells $44.9K of Stock

James Scott Ritter, CAO, sold 3,500 shares of Sportradar Group AG at $12.83 a share, worth $44.9K in total on Aug 28, 2026. Shares held after the trade: 37,113 (-8.6%).

Value
$44.9K
Shares
3,500
Price
$12.83
Role
CAO
Holding change
-8.6%
Trade date
Aug 28, 2026
4:21 PM ET 8-K
Business Update Artisan Partners Asset Management Inc. APAM

Artisan Partners Asset Management Business Update

Artisan Partners Asset Management reported preliminary assets under management (AUM) of $167.8 billion as of October 31, 2026. The firm's AUM is diversified across several investment teams, with the International Value Group and Global Value Team representing the largest portions at $58.7 billion and $33.0 billion respectively.

4:21 PM ET 8-K
Loan & Debt Asana, Inc. ASAN

Asana $150M Debt Financing with Wells Fargo Bank, National Association

Asana, Inc. entered into a new $150 million senior secured revolving credit facility with Wells Fargo and MUFG Bank. The facility includes sub-limits for letters of credit and swingline loans and matures on November 9, 2031. The funds are intended for working capital and general corporate purposes, though no amounts were drawn at closing.

Value
$150M
Counterparty
Wells Fargo Bank, National Association
Term
5 years
4:21 PM ET Form 4
Insider Selling Amkor Technology, Inc. AMKR

Amkor Technology President and CEO Kevin K. Engel Sells $35K of Stock

Kevin K. Engel, President and CEO, sold 1,000 shares of Amkor Technology, Inc. at $35.00 a share, worth $35K in total on Nov 9, 2026. Shares held after the trade: 8,666 (-10.3%).

Value
$35K
Shares
1,000
Price
$35.00
Role
President and CEO
Holding change
-10.3%
Trade date
Nov 9, 2026
4:21 PM ET Form 4
Insider Selling Crown Castle Inc. CCI

Crown Castle VP and Controller Robert Sean Collins Sells $222K of Stock

Robert Sean Collins, VP and Controller, sold 2,500 shares of Crown Castle Inc. at $88.87 a share, worth $222K in total on Nov 6, 2026. Shares held after the trade: 2,613 (-48.9%).

Value
$222K
Shares
2,500
Price
$88.87
Role
VP and Controller
Holding change
-48.9%
Trade date
Nov 6, 2026
4:21 PM ET Form 4
Insider Selling Vertex Pharmaceuticals Inc VRTX

Vertex Pharmaceuticals CEO & President Reshma Kewalramani Sells $6.31M of Stock

Reshma Kewalramani, CEO & President, sold 11,866 shares of Vertex Pharmaceuticals Inc at $531.53 a share, worth $6.31M in total on Nov 6, 2026. Shares held after the trade: 86,471 (-12.1%).

Value
$6.31M
Shares
11,866
Price
$531.53
Role
CEO & President
Holding change
-12.1%
Trade date
Nov 6, 2026
4:20 PM ET 8-K
Financial Results Marchex Inc MCHX

Marchex Financial Results

Marchex reported third quarter 2026 financial results, returning to revenue growth and GAAP profitability with $16.0 million in revenue and $1.3 million in net income. The company highlighted commercial momentum following its Archenia acquisition, including the expansion of AI Voice Agent deployments and automotive OEM distribution. Additionally, Travis Fairchild was appointed as President of the company.

Term
Q3 2026

“Our third quarter results reflect a new phase of growth and meaningful progress in strengthening Marchex's financial performance, with year-over-year revenue growth, positive GAAP net income, and a significant improvement in Adjusted EBITDA.”

Russell Horowitz, Chairman of Marchex

“By bringing together Marchex's conversational intelligence and analytics with Archenia's AI-powered customer qualification and acquisition technologies, we are creating a differentiated platform that connects customer insights with automated actions and measurable business outcomes.”

Russell Horowitz, Chairman of Marchex
4:20 PM ET Form 4
Insider Selling Eplus Inc PLUS

Eplus COO Darren S. Raiguel Sells $177K of Stock

Darren S. Raiguel, COO, sold 1,896 shares of Eplus Inc at $91.37 to $96.02 a share (average $93.12) in 5 transactions, worth $177K in total between Nov 6, 2026 and Nov 9, 2026. Shares held after the trade: 65,036 (-0.2%).

Value
$177K
Shares
1,896
Average price
$93.12
Role
COO
Holding change
-0.2%
Trade date
Nov 6, 2026 to Nov 9, 2026
4:20 PM ET Form 4
Insider Selling Lincoln National Corp LNC

Lincoln National EVP, GC & Chief Gov Officer CraigT T. Beazer Sells $764K of Stock

CraigT T. Beazer, EVP, GC & Chief Gov Officer, sold 17,980 shares of Lincoln National Corp at $42.50 a share, worth $764K in total on Nov 9, 2026. Shares held after the trade: 87,702 (-17.0%).

Value
$764K
Shares
17,980
Price
$42.50
Role
EVP, GC & Chief Gov Officer
Holding change
-17.0%
Trade date
Nov 9, 2026
4:20 PM ET 8-K
Financial Results Astronics Corp ATRO

Astronics Financial Results

Astronics Corporation reported record third quarter 2026 financial results, with sales growing 28.5% to $271.7 million and record operating income of $54.0 million. The company achieved a book-to-bill ratio of 1.00 and maintained its full-year 2026 revenue guidance of $1.02 billion to $1.04 billion.

“We delivered a strong third quarter, with record sales and operating income and an adjusted EBITDA margin near its all-time high. These results reflect disciplined operational execution and strong demand across our markets. Bookings were a solid $271.1 million following the prior quarter that had benefited from a couple of large program awards. We expect momentum to continue as we head into the final quarter of the year.”

Peter J. Gundermann, Chairman, President and Chief Executive Officer
4:20 PM ET Form 4
Insider Buying Liberty Latin America Ltd. LILA

Liberty Latin America Insider John C. Malone Buys $221K of Stock

John C. Malone bought 11,017 shares of Liberty Latin America Ltd. at $20.08 a share, worth $221K in total on Nov 6, 2026. Shares held after the trade: 3,057.

Value
$221K
Shares
11,017
Average price
$20.08
Trade date
Nov 6, 2026
4:19 PM ET 8-K
Business Update GoPro, Inc. GPRO

GoPro Business Update

GoPro filed a notification of late filing for its Q3 2026 Form 10-Q due to ongoing material weaknesses in internal controls over the valuation of financing arrangements. The company is also actively seeking waivers from lenders for covenant noncompliance that could otherwise trigger an event of default and debt acceleration.

4:19 PM ET 8-K
Leadership Change HawkEye 360, Inc. HAWK

HawkEye 360 Leadership Change

HawkEye 360 appointed former CIA Director Ambassador William J. Burns to its Board of Directors as a Class II director. Ambassador Burns will receive an annual cash retainer of $50,000 and an initial one-time grant of restricted stock units valued at $400,000. His appointment brings significant national security and diplomatic expertise to the company as it expands its signals intelligence capabilities for defense and intelligence missions.

Counterparty
William J. Burns
Term
through 2028 annual meeting
4:19 PM ET 10-Q
Financial Results BlackRock Monticello Debt Real Estate Investment Trust

BlackRock Monticello Debt Real Estate Investment Trust Q3 2026 Results: Turns Profitable, Net Income $6.78M

This filing contains a Section 13(r) disclosure regarding a minority non-controlling interest in Malaysia Airports Holdings Berhad held by BlackRock affiliates. The disclosure reports that Iran Airtour resumed flight operations to one of the airports operated by Malaysia Airports Holdings Berhad starting in August 2026.

Key figure
Net income $6.78M
4:19 PM ET 8-K
Financial Results BridgeBio Oncology Therapeutics, Inc. BBOT

BridgeBio Oncology Therapeutics Financial Results

BridgeBio Oncology Therapeutics reported financial results for the third quarter of 2026, highlighting a cash runway expected to fund operations into 2029. The company reported clinical progress for its RAS-pathway inhibitors, including a 75% objective response rate for BBO-8520 in combination with pembrolizumab in certain lung cancer patients. Management expects monotherapy data updates for BBO-11818 and BBO-10203 in the fourth quarter of 2026.

Term
Q3 2026

“The third quarter was an important period for BBOT as we reported updated clinical data for BBO-8520 and delineated our strategic focus. Driven by encouraging clinical data across all three programs we are executing on multiple combinations with the potential for significant patient benefit.”

Pedro J. Beltran, Ph.D., Chief Executive Officer of BBOT

“With a strong balance sheet, multiple data catalysts expected through mid-2027, and cash runway into 2029, we believe BBOT is well positioned to advance differentiated therapies for patients with KRAS-driven cancers.”

Pedro J. Beltran, Ph.D., Chief Executive Officer of BBOT

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.